Keto

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Keto

Quick Facts about Ketoprofen

Property Description
Active ingredient Ketoprofen
Form Tablet, Gel, Capsule, Injection (Varies)
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common use (General) Alleviates pain, inflammation, and fever
Origin Synthetic compound (Propionic acid derivative)

The Classification and Identity of Keto (Ketoprofen)

The medication commonly associated with the name Keto is defined by its active ingredient, Ketoprofen, a potent substance classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Ketoprofen is a synthetic compound derived from the Propionic acid chemical group. This classification defines it as a medication designed to exert anti-inflammatory, analgesic (pain-relieving), and antipyretic (fever-reducing) effects simultaneously. It provides efficacy within the NSAID group for treating symptoms associated with inflammatory conditions, distinguishing it from non-NSAID fever reducers.

General Purpose: What Is Keto Used to Alleviate?

The general purpose of Ketoprofen is to manage and mitigate the body's inflammatory response, primarily addressing the symptoms of pain, inflammation (swelling), and fever. The mechanism involves Cyclooxygenase (COX) inhibition, a key physiological action that restricts the production of local chemical messengers called prostaglandins. This targeted action allows the medication to dampen the signaling of discomfort and reduce localized tissue reaction. As an NSAID, Ketoprofen provides effective management of these acute symptoms. The medication is used for reducing uncomfortable symptoms like swelling and tenderness.

Ketoprofen: Available Forms and Administration Routes

Ketoprofen is formulated into a range of diverse dosage forms to suit specific therapeutic needs, allowing for both systemic and localized action. These pharmaceutical preparations include solid forms like the Tablet and Capsule for Oral use, as well as specialized formulations such as Gel, Cream, and Transdermal patch for Topical administration. The availability of diverse forms permits targeted relief—for instance, using a topical gel to manage localized muscle discomfort—or systemic relief via an oral tablet for generalized symptoms.

What side effects are possible with Keto?

Possible Side Effects and Safety Information

The safety profile of oral ketoconazole is defined by several serious and potentially life-threatening risks, which have led government regulatory bodies to restrict its use to specific severe fungal infections when alternative therapies are unavailable or not tolerated.

Serious and Clinically Significant Risks

Official regulatory documents emphasize the following serious adverse reactions:

  • Severe Hepatotoxicity (Liver Injury): Keto carries a risk of serious liver injury, including cases of hepatitis, cirrhosis, and fatal liver failure, or cases requiring liver transplantation. This risk is present regardless of the duration or dose of treatment.
  • Adrenal Insufficiency: The medication can reduce adrenal corticosteroid secretion, potentially leading to adrenal insufficiency, particularly at higher doses.
  • Cardiac Arrhythmias: There is a significant risk of life-threatening ventricular dysrhythmias, such as Torsades de pointes, due to its potential to prolong the QT interval when taken concurrently with certain other medications.

Adverse Reactions by Frequency

Commonly reported adverse reactions (occurring in 1% to 10% of patients) include gastrointestinal issues such as nausea and vomiting.

Safety-Related Restrictions and Contraindications

Official regulatory sources note the following critical limitations:

  • Contraindications: The medicine is contraindicated in patients with acute or chronic liver disease, as well as in patients taking specific drugs known to cause QT prolongation (e.g., dofetilide, quinidine) or other contraindicated medications metabolized by the CYP3A4 enzyme.
  • Monitoring Requirements: Baseline and regular monitoring of liver function (e.g., ALT, AST, TBL) and, in some cases, adrenal function are required throughout treatment due to the documented safety risks.

Population-Specific Notes

The drug is contraindicated in pregnancy due to the potential for fetal harm. Regulatory documents also note potential reproductive toxicity hazards, including effects on fertility and sperm quality.

Overdose and Emergency Response

Overdose Manifestations and Severity

The official regulatory documents define the potential manifestations of Ketoprofen overdose across several physiological systems. Documented presentations primarily involve the gastrointestinal tract, including nausea, vomiting (sometimes with blood), stomach pain, and epigastric pain. Central nervous system signs include drowsiness, dizziness, headache, and confusion.

Overdose carries the risk of severe and potentially life-threatening outcomes, such as acute renal failure, seizures, and coma. The most critical documented risks involve serious gastrointestinal adverse events like internal bleeding or perforation, which are associated with fatal outcomes. The labeling notes that elderly patients are at increased risk for these severe GI complications.

Required Emergency Actions

In the event of a suspected overdose, regulatory guidance mandates that patients or caregivers immediately contact the Poison Control Helpline for instructions. Furthermore, emergency medical help must be sought right away if severe symptoms are present, including shallow breathing, uncontrolled bleeding, chest pain, or slurred speech.

No specific antidote for Ketoprofen overdose is currently known. Therefore, treatment is defined as symptomatic and supportive. Regulator-documented supportive measures may include administering activated charcoal for decontamination and continuous hospital monitoring, which involves conducting tests such as an Electrocardiogram (ECG).

Therapeutic Uses of Keto

The primary role of Ketoprofen (Keto) is commonly used to help with symptomatic support across conditions marked by pain, inflammation, and fever, helping patients manage the symptom burden associated with acute and chronic health issues.

The medication is relevant for managing symptoms associated with chronic inflammatory joint conditions, including rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. It is also applied during acute episodes like gout flares, post-traumatic events such as sprains and strains, and to address postoperative pain. Furthermore, it may assist in addressing intense discomfort from primary dysmenorrhea (menstrual cramping) and systemic symptoms related to fever.

“It provides support that helps ease the overall symptom burden and supports patients during difficult episodes by easing distress.”

Ketoprofen helps address symptom clusters that may become intense, contributing to easing the overall symptom load during symptomatic periods.


Quick Fact: Symptomatic Support

Symptom Category Therapeutic Context Patient Benefit
Pain, Swelling, Stiffness Chronic arthritis, Musculoskeletal trauma May assist with maintaining functional stability
Menstrual Cramping, Fever Episodic pain, Systemic imbalance Contributes to easing the overall symptom load

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Ketoprofen

This section outlines the officially documented population eligibility and non-eligibility for Ketoprofen (Keto), based strictly on government regulatory documents.


Eligibility Scope

Eligibility Category Official Regulatory Statement
Populations for whom use is allowed Adults (18 years and older); Adolescents (typically 15 years and older for some oral forms).
Populations for whom use is not recommended Children under 12 or 15 years (Safety and efficacy not established); First and second trimesters of pregnancy (use only if clearly essential).
Populations for whom use is contraindicated Patients with Hypersensitivity to Ketoprofen, aspirin, or other NSAIDs, including those with aspirin-induced asthma; Third trimester of pregnancy; Active peptic ulceration, GI bleeding, or perforation; Severe heart failure; Severe renal impairment (CrCl < 30 mL/min) or Severe hepatic impairment; Peri-operative pain following CABG surgery.
Age-related eligibility rules Use not recommended for children under specified ages; Older Adults (Geriatric) require cautious use and typically a lower initial dose.
Condition-specific eligibility rules Patients with mild to moderate renal or hepatic impairment require dose adjustment and close monitoring; Caution is advised for patients with uncontrolled hypertension or mild to moderate heart failure.
Pregnancy and lactation eligibility status Pregnancy (Third Trimester): Contraindicated. Breastfeeding/Lactation: Not recommended.

Connection to the Overall Eligibility Profile

Regulatory documents establish the population boundaries for Ketoprofen primarily through Contraindications, which strictly prohibit use in patients with severe co-existing conditions like severe organ failure or active GI bleeding. Eligibility is typically reserved for adults and older adolescents who do not meet these contraindication criteria. Additional restrictions mandate caution or dose reduction for older adults and those with compromised organ function, ensuring adherence to the medicine's labeled population rules.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ketoconazole is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme, which is responsible for metabolizing many other medications. This mechanism results in a high risk of drug-drug interactions, leading to specific regulatory constraints.


Critical Co-administration Restrictions

Regulatory agencies strictly contraindicate the co-administration of Ketoconazole with specific medicines due to the risk of life-threatening events. These include Simvastatin and Lovastatin (risk of myopathy/rhabdomyolysis), Pimozide, Quinidine, and Dofetilide (risk of severe QT prolongation and Torsades de pointes), and certain benzodiazepines like oral Midazolam and Triazolam (risk of enhanced sedation).


Pharmacokinetic Interaction Profile

Mechanism Interacting Substances/Classes Constraint
Inhibition of CYP3A4 Numerous substrates (e.g., Sirolimus, Sildenafil, Oral Anticoagulants) Requires dose adjustment or monitoring of the co-administered drug.
Reduced Absorption Gastric Acid Reducers (e.g., PPIs, Antacids) Requires dose separation or administration with an acidic beverage to maintain Ketoconazole plasma levels.
Enzyme Induction CYP3A4 Inducers (e.g., Rifampin, Phenytoin) Results in decreased Ketoconazole plasma levels, reducing effectiveness.

Other Documented Product Constraints

The consumption of Alcohol is restricted due to the documented risk of severe liver damage and a disulfiram-like reaction. Furthermore, official labeling notes that in patients with low gastric acidity, administration with an acidic beverage may be required to ensure proper absorption.

Mechanism of Action

The core mechanism of Ketoprofen is the reversible non-selective inhibition of Cyclooxygenase (COX) enzymes, targeting both the constitutive COX-1 and the inducible COX-2 isoforms. This action blocks the initial molecular steps of the Arachidonic Acid Cascade, preventing the synthesis of signaling molecules known as prostaglandins. The downstream consequence of prostaglandin suppression is dual: it modulates peripheral signaling by reducing the sensitization of nociceptors, and it resets central thermoregulation by adjusting the elevated temperature set-point in the hypothalamus. These simultaneous molecular ightarrow physiological changes define the resulting adjustment in the body's nociceptive signaling, local vascular dynamics, and core thermal set-point. The mechanism is pathology-dependent, offering limited functional consequence for states driven by non-eicosanoid pathways.

Dosage and Administration Information

How to Use Ketoprofen (Keto): Administration Guidelines

Ketoprofen administration involves distinct approaches for systemic (oral) and localized (topical) use. Standard practice involves using the lowest effective dose for the shortest duration necessary.


Administration Scope and Dosing Regimens

Administration Type Dosing Schedule Maximum Daily Dose Official Route
Oral (Immediate-Release) 25 mg to 75 mg three or four times daily, or as needed 300 mg Oral
Oral (Extended-Release) 200 mg once daily (QD) 200 mg Oral
Topical Gel Two to four applications daily 15 g Topical

Contextual Use and Administration Rules

Oral Administration:

  • Food Relationship: Oral capsules may be taken with food, milk, or an antacid to assist in minimizing gastrointestinal discomfort.
  • Form Restrictions: The Extended-Release capsule is not recommended for acute pain. Concurrent use of Immediate-Release and Extended-Release formulations is also not recommended.

Topical Administration:

  • Application Constraints: The gel should not be applied to mucous membranes, eyes, or open wounds and must not be used under occlusive dressings.

Population-Specific Adjustments:

  • Older Adults & Impairment: Dose reduction is used for older adults (e.g., those over 75 years) and for patients presenting with severe renal or hepatic impairment, where the maximum total daily dose may be reduced to 100 mg.
  • Pediatric Use: Safety and effectiveness have not been established for children under a certain age (e.g., 12 or 15 years); use is generally not authorized in this population.

Recent Clinical Evidence

Research evidence / Overview of Studies for Ketoprofen (Keto)

Evidence for Symptom Management in Chronic Joint Conditions

The research exploring symptomatic patterns in chronic conditions, such as those associated with rheumatoid arthritis and osteoarthritis, primarily relies on short-to-intermediate-term Randomized Controlled Trials (RCTs) and subsequent systematic reviews. Research examined outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level. Studies monitored and documented changes in assessed symptomatic parameters during the specific study period, often spanning six to twelve weeks. The research was applied to assess short-term changes in symptoms and functional metrics, but did not focus on changes in the underlying disease progression.

Evidence for Acute Pain and Musculoskeletal Injury

Research explored the use of Ketoprofen for addressing acute, non-chronic issues, such as pain following soft tissue injuries like sprains and strains, and pain experienced after surgery. This evidence is derived mainly from short-term RCTs; research examined both oral capsule/tablet forms and localized topical forms. Findings document observed patterns related to the time until initial changes were measured and the overall change in assessed discomfort metrics in the immediate aftermath of an injury or procedure. A primary research limitation is that the follow-up durations were limited, often covering only the first few days or weeks post-event.

What is Still Uncertain About Ketoprofen Research

Certainty remains low regarding the full spectrum of long-term effects, as follow-up durations were limited across many key efficacy trials. Findings were varied in some comparative trials, and research reports inconsistent or insufficient comparative evidence against many alternative treatments. Furthermore, findings describe group patterns, not personal outcomes; research cannot predict whether an individual will respond similarly, as study results reflect the specific conditions under which they were conducted. The research base requires further evaluation to fully understand the patterns observed when Ketoprofen is used continuously for many months or years.

Key Studies & References

  1. Safety of ketoprofen compared with ibuprofen and diclofenac: a systematic review and meta-analysis
  2. PRODUCT MONOGRAPH KETOPROFEN (Regulatory document detailing approved indications and clinical trial summary data)
  3. Ketoprofen - LiverTox (NIH): Used for context on chronic arthritis and acute pain indications and post-marketing surveillance context
  4. Intravenous Dexketoprofen versus Intravenous Paracetamol for Dysmenorrhea: A Randomized Controlled Trial (used for context on episodic pain and acute study design)

Frequently Asked Questions (FAQ)

Common questions about Keto (FAQ)

Q: How quickly should I expect Keto to start working?

According to official product information, the active ingredient's concentration in the bloodstream typically reaches its peak within one to two hours after a person takes the oral capsule. This pharmacokinetic pattern is what determines the onset of the medicine's effects.


Q: Does Keto interact with common pain relievers like ibuprofen?

Keto is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Regulatory documents include warnings against using it concurrently with other NSAIDs, such as ibuprofen. Using more than one NSAID at the same time is described as significantly increasing the risk of serious gastrointestinal side effects.


Q: Can I take Keto if I am already taking a supplement?

Official prescribing information typically focuses on interactions with other prescription medications. However, warnings exist for products that may affect liver enzymes or increase the risk of bleeding, and some supplements could potentially fall into these categories. The official process is to review the complete list of all supplements with the healthcare provider prescribing the medicine.


Q: What happens if I miss taking a dose of Keto?

Patient information often includes guidance describing how a missed dose may be handled. This typically involves descriptions of when a dose may be taken upon remembering, and when it is specified that the missed dose should be set aside if it is too close to the time for the next scheduled dose.


Q: Is it true that Keto can affect my sleep?

Yes, official labeling lists potential effects on the central nervous system. These documented adverse reactions include both insomnia (difficulty falling or staying asleep) and somnolence (drowsiness).


Q: How long do most people stay on Keto treatment?

Official prescribing information mandates that the medicine adhere to the principle of using the lowest effective dose for the shortest possible duration. This regulatory guidance ensures treatment is limited to the time necessary to manage the patient's symptoms.


Q: Is Keto a new drug, or has it been around for a while?

Ketoprofen, the active ingredient in Keto, is an established medicine with a long history. Official records indicate that the active compound was patented in 1967 and was subsequently approved for medical use in various regions in the early 1980s.


Q: Is it normal to feel a mild headache when first starting Keto?

Official regulatory labeling lists headache as one of the commonly reported adverse reactions associated with the medicine. This pattern is noted in official documents provided to patients and healthcare providers.


Q: Are there different brand names for the medicine Keto?

Yes, the active ingredient in Keto is Ketoprofen. Regulatory and national drug databases confirm that Ketoprofen is available under multiple approved brand names, in addition to being marketed as a generic product.


Q: Will Keto change the results of blood tests?

Official documents state that the medicine carries a risk of hepatotoxicity (liver injury). Due to this documented risk, baseline and regular monitoring of liver function tests (such as ALT and AST) are officially required throughout treatment.


Q: What does 'contraindicated' mean in the context of Keto?

The term 'contraindicated' is a crucial term in medical guidance that means the medicine should not be used under any circumstances in patients with certain severe pre-existing conditions. Regulatory documents define these conditions (such as active ulcers or severe organ failure) where the potential risks are definitively known to outweigh any benefit.


Q: Is Keto available over the counter, or is it prescription only?

The majority of Ketoprofen dosage forms require a valid prescription from a licensed healthcare provider. However, official regulatory status can vary by country, and in some regions, specific low-dose topical or oral formulations may be authorized for purchase without a prescription.


Q: Have there been any major studies on Keto published recently?

Regulatory agencies consistently review new clinical data regarding all approved medicines. The most recent official summaries of studies that support the current usage and safety profile are contained within the Clinical Studies section of the approved prescribing information.


Q: Is Keto known to cause weight gain or weight loss?

Official labeling lists edema (fluid retention or swelling) as a potential adverse reaction. Fluid retention is a documented pattern that can lead to a measurable increase in weight.


Q: Does taking Keto affect my ability to drive or operate machinery?

Official warnings describe that activities requiring focused attention, such as driving or operating machinery, may be impaired if side effects like dizziness, drowsiness, or visual disturbances are experienced. These effects are documented in regulatory labeling.


Q: How is Keto eliminated from the body?

Pharmacokinetic information detailed in official regulatory documents describes how the medicine leaves the body. Keto is primarily metabolized by the liver, and the medicine and its inactive components are then eliminated from the body mostly through the urine.


Q: Does Keto affect the efficacy of birth control pills?

Official drug interaction lists specify warnings for co-administration with various medications. Specific guidance and warnings regarding the use of hormonal contraceptives with this medicine are contained within the regulatory drug labeling.


Q: What should I do if a side effect of Keto doesn't go away?

Official guidance found in patient information describes that persistent, worsening, or severe side effects are to be reported immediately to a healthcare provider. This reporting requirement is mandated due to documented safety concerns.


Q: Can Keto interact with herbal remedies like St. John's Wort?

Official documents include a warning for interactions with prescription drugs that are strong enzyme inducers. Since certain herbal products, such as St. John's Wort, can act as enzyme inducers, they may reduce the medicine's effectiveness.


Q: What information is provided on the Keto packaging or leaflet?

Regulatory bodies mandate that the patient information leaflet must contain standardized sections. These include the medicine's intended purpose, all warnings and contraindications, potential side effects, administration guidance, and storage requirements.


Q: How is the safety of Keto monitored after it has been approved?

Safety is continuously monitored by regulatory agencies after the medicine is approved for the market. This process is known as Post-Marketing Surveillance and includes a mandatory system for healthcare professionals to report suspected adverse events.


Q: Is there a generic version of Keto available?

Yes, regulatory databases, such as the FDA's Orange Book and national registers, confirm the approval of generic versions. This means that multiple manufacturers produce and market generic versions of the active ingredient, Ketoprofen.


Q: Does Keto affect mental focus or concentration?

Official side effect listings include central nervous system effects such as dizziness, vertigo, and somnolence. These are documented reactions that may impair a patient's mental focus or concentration.

How should Keto be stored and disposed of?

How to Store and Dispose of Ketoprofen

The storage and disposal of Ketoprofen must strictly follow regulatory guidance to ensure product integrity and safety.

Official Storage Conditions

Ketoprofen oral forms (tablets/capsules) must be stored at controlled room temperature, specifically 20° to 25°C (68° to 77°F). The product must be protected from excess heat and moisture; therefore, it should not be stored in humid areas like the bathroom. The container must be kept tightly closed in its original packaging.

Child Safety and Handling

All forms of Ketoprofen must be stored out of the sight and reach of children and kept in a safe, up-and-away location. Certain topical gels also require being kept away from naked flames and the cap must be replaced after use.

Disposal Requirements

Ketoprofen is not on the FDA's flush list. Unused or expired medication should be discarded via a community drug take-back program. If a program is unavailable, mix the medicine with an undesirable substance (e.g., dirt or coffee grounds) and place the mixture in a sealed bag before disposal in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Keto found in:

A-Z Index: